Skip to main content

Table 1 Baseline characteristics for the Saudi Initiative for Asthma group and the Global Initiative for Asthma group

From: Utilization and responsiveness of the asthma control test (ACT) at the initiation of therapy for patients with asthma: a randomized controlled trial

Characteristics

SINAagroup

GINAb group

pvalue

Number of patients

45

45

 

Age, years (± SD)

42.9 (± 13.4)

42.3 (± 12.6)

0.840

Gender

   

- Male, No. (%)

14 (31.1%)

19 (42.2%)

0.274

- Female, No. (%)

31 (68.9%)

26 (57.8%)

 

Body mass index, No. (± SD)

32.6 (± 7.4)

34.0 (± 7.3)

0.370

Disease duration, years (± SD)

10.9 (± 9.3)

10.1 (± 8.6)

0.630

Respiratory Symptoms

   

- Cough, No. (%)

27 (60.0%)

22 (48.9%)

0.290

- Shortness of breath, No. (%)

10 (22.2%)

15 (33.3%)

0.239

- Wheezing, No. (%)

7 (15.6%)

9 (20.0%)

0.581

Asthma attacks in the past 4 weeks, No. (%)

1.5 (± 1.1)

1.8 (± 1.5)

0.378

Initial visit Peak Flow meter, value (± SD) (L/min)

343.1 (± 129.5)

362.9 (± 148.8)

0.143

Initial visit Forced Expiratory volume in 1 second, Percentage of normal (± SD)

81.4% (± 17.1)

84.3% (± 16.2)

0.269

Initial visit asthma control test score, score (± SD)

17.6 (± 4.5)

17.8 (± 3.6)

0.776

  1. a SINA: Saudi Initiative for Asthma; b GINA: Global Initiative for Asthma